glp 1 colon cancer GLP-1 receptor agonists—the class of drugs behind Ozempic, Wegovy, and Mounjaro—may do more than regulate blood sugar and weight. ⁠ ⁠ In an analysis of more than 6,800 patients across GLP-1s show 'mind-blowing' effect on

The side effects of using long-term ICS include oropharyngeal candidiasis, vocal cord changes, nasal bleeding, and mucosal irritation

Heres what that looks like in practice in 2026: Pennsylvania eliminated GLP-1 coverage for adult weight loss (21+) starting January 1, 2026

Weight Loss Effectiveness: What the Research Shows When you're deciding between these medications, the weight loss results matter a lot

Very happy my energy level is back I feel alive Like the energy and results

Excited to keep building with Sprouts and grow this the right way

Below is a framework comparing theoretical transfer risk factors for common GLP-1 medications based on known pharmacokinetics and analogous drug classes